|
Volumn 277, Issue 5332, 1997, Pages 1602-1603
|
Blunting nature's swiss army knife
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
CATHEPSIN;
CYSTATIN;
METALLOPROTEINASE;
N (1 HYDROXY 2 NAPHTHOYL)ARGINYLPROLINAMIDE;
N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;
PROTEINASE INHIBITOR;
TISSUE INHIBITOR OF METALLOPROTEINASE;
TRYPTASE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ASTHMA;
BLOOD CLOTTING;
CLINICAL TRIAL;
COMMON COLD;
DRUG TARGETING;
HUMAN;
MEDICAL RESEARCH;
NONHUMAN;
NOTE;
OSTEOPOROSIS;
PANCREAS CANCER;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
SCHISTOSOMIASIS;
ANIMALS;
ASTHMA;
CHYMASES;
CLINICAL TRIALS;
COMMON COLD;
CORONAVIRUS INFECTIONS;
DIPEPTIDES;
DRUG DESIGN;
FACTOR XA;
HUMANS;
NEOPLASMS;
OSTEOPOROSIS;
PROTEASE INHIBITORS;
SCHISTOSOMIASIS;
SERINE ENDOPEPTIDASES;
TRYPTASES;
|
EID: 0030864046
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.277.5332.1602 Document Type: Note |
Times cited : (43)
|
References (0)
|